摘要
目的研究和分析中药丹红注射液联合口服药物步长脑心通胶囊用于治疗冠心病心绞痛患者的临床疗效,为临床治疗提供可借鉴依据。方法选取该院自2013年10月—2014年9月诊治的105例冠心痛心绞痛住院患者作为研究对象,根据治疗方案的需要分为两组,其中对照组53例使用一般治疗方法,治疗组52例在一般治疗的基础上使用药物丹红注射液与口服步长脑心通胶囊治疗,然后对比两组患者治疗前后的临床效果,并观察记录不良反应发生的情况。结果经过2周的治疗,治疗组患者的总有效率为96.2%(50/52),明显地高于对照组患者(79.2%,42/53),两组患者的总有效率对比,存在明显的差异有统计学的意义(χ2=5.038,P<0.05)。该两组患者均没有严重不良反应现象发生。结论对于冠心病心绞痛患者,运用药物丹红注射液与口服步长脑心通胶囊联合治疗,临床效果非常显著,可以作为临床首选的治疗方案,值的临床推广。
Objective research and analysis of traditional Chinese medicine of Danhong injection combined with oral drugs Buchang Naoxintong capsule for the clinical curative effect of the treatment of patients with coronary heart disease and angina pectoris, provide the reference for the clinical treatment of. Methods 105 cases in our hospital from 2013 October to crown a 2014 and September angina patients hospitalized patients as the research object, according to the need of treatment were divided into two groups, one control group 53 cases using conventional treatment, the treatment group 52 cases in the general treatment based on the use of drugs of Danhong injection and oral step brain Naoxintong treatment, then compare the clinical effect of two groups before and after treatment, and the adverse reactions were observed to happen. Results after 2 weeks of treatment, the patients in the treatment group the total effective rate was 96.2%（50/52）, significantly higher than the patients in the control group（79.2%, 42/53）, the total efficiency compared two groups of patients, there were obvious differences （χ2=5.038, P 〈0.05）, with statistical sig-nificance. The two groups of patients did not occur the phenomenon of serious adverse reactions. Conclusion for patients with angina pectoris of coronary heart disease, the use of drugs of Danhong injection and oral Buchang Naoxintong capsule combined with treatment, the clinical effect is very significant, can be used as the first choice in clinical treatment, clinical spread value.
出处
《中外医疗》
2015年第3期162-163,共2页
China & Foreign Medical Treatment
